Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

MYELODYSPLASTIC SYNDROME

Known as: Myelodysplastic Syndromes, Myelodysplastic Syndromes [Disease/Finding], Myelodysplastic Syndrome/Neoplasm 
A clonal hematopoietic disorder characterized by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines. The… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Myelodysplastic syndromes (MDS) are a heterogeneous group of chronic hematological malignancies characterized by dysplasia… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2012
Highly Cited
2012
The International Prognostic Scoring System (IPSS) is an important standard for assessing prognosis of primary untreated adult… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Highly Cited
2011
Highly Cited
2011
BACKGROUND Myelodysplastic syndromes are clinically heterogeneous disorders characterized by clonal hematopoiesis, impaired… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Highly Cited
2009
Highly Cited
2009
BACKGROUND Drug treatments for patients with high-risk myelodysplastic syndromes provide no survival advantage. In this trial, we… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Review
2009
Review
2009
  • P. Nguyen
  • Hematology/oncology clinics of North America
  • 2009
  • Corpus ID: 831498
Myelodysplastic syndromes (MDS) are a heterogeneous group of bone marrow disorders that affect mostly the elderly and have a… Expand
  • figure 2
  • figure 3
Highly Cited
2006
Highly Cited
2006
Aberrant DNA methylation, which results in leukemogenesis, is frequent in patients with myelodysplastic syndromes (MDS) and is a… Expand
Highly Cited
2002
Highly Cited
2002
PURPOSE Patients with high-risk myelodysplastic syndrome (MDS) have high mortality from bone marrow failure or transformation to… Expand
Highly Cited
1997
Highly Cited
1997
Despite multiple disparate prognostic risk analysis systems for evaluating clinical outcome for patients with myelodysplastic… Expand
  • table 1
  • table 2
  • figure 1
  • figure 3
  • figure 4
Highly Cited
1982
Highly Cited
1982
Summary. New, diagnostic criteria for the diagnosis of the various myelodysplastic syndromes (MDS) are proposed, and a detailed… Expand
Highly Cited
1976
Highly Cited
1976
Summary. A uniform system of classification and nomenclature of the acute leukaemias, at present lacking, should permit more… Expand